Last €38.74 EUR
Change Today +0.19 / 0.49%
Volume 199.0
BRM On Other Exchanges
Symbol
Exchange
New York
Mexico
Sao Paulo
Frankfurt
As of 5:24 AM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles A. Bancroft

Chief Financial Officer and Executive Vice President, Bristol-Myers Squibb Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$7,878,016
As of Fiscal Year 2013

Background*

Mr. Charles A. Bancroft, also known as Charlie, has been Chief Financial Officer and an Executive Vice President of Bristol-Myers Squibb Company since April 8, 2010 and October 2011 respectively. Mr. Bancroft served as Acting Chief Financial Officer of Bristol-Myers Squibb Co. from January 1, 2010 to April 8, 2010. He served as Vice President of finance at Bristol-Myers Squibb's global biopharmaceutical business. Mr. Bancroft joined Bristol-Myers in 1984 and has since ...

Read Full Background

Corporate Headquarters*

345 Park Avenue
New York, New York 10154

United States

Phone: 212-546-4000
Fax: 212-546-4020

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Drexel University
MBA
Temple University

Other Affiliations*

Annual Compensation*

Salary$901,092
Total Annual Compensation$901,092

Stock Options*

Restricted Stock Awards$4,778,079
All Other Compensation$311,230
Exercisable Options149,193
Exercisable Options Value$4,693,835
Total Value of Options$4,693,835
Total Number of Options149,193

Total Compensation*

Total Annual Cash Compensation$2,340,430
Total Short Term Compensation$901,092
Other Long Term Compensation$5,089,309
Total Calculated Compensation$7,878,016
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRM:GR €38.74 EUR +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.1M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.